Shares of Mylan surged more than 20% in early trading on Monday after the EpiPen maker agreed to merge with Pfizer's off-patent drug unit. Pfizer shareholders will own 57% of the new company, and the remainder will be owned by shareholders of Mylan, according to a statement from the companies. The new drugmaker will be rebranded and renamed, and is expected to generate between $19 billion and $20 billion in annual sales. Watch Mylan trade live.
Shares of Mylan surged more than 20% in early trading on Monday after the EpiPen maker agreed to merge with Pfizer's off-patent drug unit. Pfizer shareholders will own 57% of the new company, and the remainder will be owned by shareholders of Mylan, according to a statement from the companies. The new drugmaker will be rebranded and renamed, and is expected to generate between $19 billion and $20 billion in annual sales. Watch Mylan trade live.
Hope they plan on covering funeral expenses.
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Pfizer in talks to merge off-patent drugs business with MylanPfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a... Further consolidation that will result in increased drug prices. Republicans will say this is free market principals. Americans will blame Democrats either way.
Fuente: Reuters - 🏆 2. / 97 Leer más »
Pfizer in talks to merge off-patent drugs business with Mylan: sourcePfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a... Seriously can we STOP all the mega mergers Mylan was the one that increased the compensation of CEO HeatherBresch (daughter of FakeDem JoeManchin) 600% while jacking up the price of the lifesaving Epipen 400%.
Fuente: Reuters - 🏆 2. / 97 Leer más »
Pfizer to Merge Off-Patent Drug Business With MylanPfizer agreed to merge its off-patent drugs business with generic drugmaker Mylan. The companies are betting that combining Pfizer’s off-patent business with Mylan will provide a pathway to reignite sales growth. And spike prices in that arena? Except, of course, the U.S., where the prices will go up 1000%. Move along, folks. Just business as usual... insert merchant meme here
Fuente: WSJ - 🏆 98. / 63 Leer más »
Pfizer plans combination of off-patent drug business with MylanThe deal, expected to be announced Monday, will result in Pfizer shareholders owning most of the new company with Mylan's shareholders owning slightly more than 40%.
Fuente: CNBC - 🏆 12. / 72 Leer más »
Pfizer and Mylan reportedly near merger deal for low-priced drugsOne company makes Xanax and Viagra. The other makes the popular EpiPen drug for people with allergies. Now they may be close to merging. You went crazy over sprint and t-mobile yesterday but this is a big win ? This proves beyond a shadow of a doubt where your priorities lays. Not a peep out of democrats and you reporting it as a good deal. This is a shame. This is why we have President Trump. Nonononononononono Hmmm, with lesser competition, it's easier for big corporations to dictate and control prices. I hope this low-price drug market goal is going to happen.
Fuente: CNN - 🏆 4. / 95 Leer más »